Annovis Bio, Inc. ( ANVS) - Stock Earnings
ANVS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
ANVS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -9.8 million USD | — USD |
| 2026Q1 | -17.6 million USD | — USD |
| 2026Q2 | -14.8 billion USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ANVS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -56.2 million USD | — USD |
| 2024 | -24.6 million USD | — USD |
| 2025 | -28.9 million USD | — USD |
| 2026 Est. | — | — |
ANVS
Price: $0.99
52 week price:
Earnings Per Share: -1.61 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 103127
Market Capitalization: 50.2 million